Adiponectin, IL-10 and metabolic syndrome in obese children and adolescents

Acta Biomedica de l'Ateneo Parmense

Volumn 80, Issue 2, 2009, Pages 117-123

  Calcaterra, Valeria ^a   de Amici, Mara ^a   Klersy, Catherine ^b   Torre, Cristina ^a   Brizzi, Vincenza ^a   Scaglia, Francesca ^a   Albanesi, Michela ^a   Albertini, Riccardo ^b   Allais, Benedetta ^a   Larizza, Daniela ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Adiponectin; Il 10; Metabolic syndrome; Obesity

Indexed keywords

ADIPONECTIN; INTERLEUKIN 10;

ADOLESCENT; ARTICLE; BODY MASS; CHILD; CHILD HEALTH; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PROTEIN BLOOD LEVEL; BLOOD; COMPARATIVE STUDY; ENZYME IMMUNOASSAY; INCIDENCE; ITALY;

ADIPONECTIN; ADOLESCENT; BODY MASS INDEX; CHILD; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; INCIDENCE; INTERLEUKIN-10; ITALY; MALE; METABOLIC SYNDROME X; OBESITY;

EID: 73349135665     PISSN: 03924203     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Ajuwon KM, Spurlock ME. Adiponectin inhibits LPS-in-duced NF-KappaB activation and IL-6 production and increases PPARgamma2 expression in adipocytes. Am J Phy-siol Regul Integr Comp Physiol 2005; 288: R1220-R1225.
2. Hong SJ, Seo HS, Rha SW, et al. Decrease in plasma adi-ponectin concentrations in patients with variant angina pectoris. Circ J 2006; 70: 414-8.
3. Maruyoshi H, Kojima S, Otsuka F, et al. Hypoadiponecti-nemia is associated with coronary artery spasm in men. Circ J 2005; 69: 1154-6.
4. Matsukawa Y.Therapy Insight: Adipocytokines in metabolic syndrome related cardiovascular disease. Nat Clin Pract Cardiovasc Med 2006; 3: 35-42.
5. Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999; 257: 79-83.
6. Hawrylowicz CM, O'Garra A. Potential role of inter-leukin-10-secreting regulatory T cells in allergy and asthma. Nat Rev Immunol 2005; 5: 271-83.
7. Mallat Z, Heymes C, Ohan J, Faggin E, Lesèche G, Ted-gui A. Expression of interleukin-10 in advanced human atherosclerotic plaques: relation to inducible nitric oxide synthase expression and cell death. Arterioscler Thromb Vasc Biol 1999; 19: 611-6.
8. Mallat Z, Besnard S, Duriez M, et al. Protective role of in-terleukin-10 in atherosclerosis. Circ Res 1999; 85: 17-24.
9. Kumada M, Kihara S, Ouchi N, et al. Adiponectin specifically increased tissue inhibitor of metallo-proteinase-1 through interleukin-10 expression in human macrophages. Circulation 2004; 109: 2046-9.
10. Nishida M, Moriyama T, Sugita Y, Yamauchi-Takihara K. Interleukin-10 associates with adiponectin predominantly in subjects with metabolic syndrome. Circ J 2007; 71: 1234-8.
11. Cacciari E, Milani S, Balsamo A, et al. Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr). J Endocrinol Inv 2006; 29: 581-93.
12. Marshall WA, Tanner JM. Variations in patterns of puber-tal changes in boys. Arch Dis Child 1969; 45: 13-23.
13. Marshall WA, Tanner JM. Variations in patterns of puber-tal changes in girls. Arch Dis Child 1969; 44: 291-303.
14. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1999; 22 Suppl 1: S5-S19.
15. Maffeis C, Pietrobelli A, Salvatoni A, et al. Obesità del bambino e dell'adolescente: consensus su prevenzione, dia-gnosi e terapia. In Argomenti di Pediatria 1/06 (ed. P. Sala-ri). Milano: Ist. Scotti Bassani; 2006: 31.
16. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents. Pediatrics 2004; 114: 555-76.
17. Calcaterra V, Klersy C, Muratori T, et al. Prevalence of metabolic syndrome (MS) in children and adolescents with varying degrees of obesity. Clin Endocrinol (Oxf) 2008; 68: 868-72.
18. Weiss R, Dziura J, Burgert TS, et al. Obesity and the metabolic syndrome in children and adolescents. New Engl J Med 2004; 350: 2362-74.
19. Third report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in adults (Adult Treatment Panel III). Bethesda, Md.: National Heart, Lung, and Blood Institute, May 2001. (NIH publication no. 01-3670)
20. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. 1. Diagnosis and classification of diabetes mellitus provision-al report of a WHO consultation. Diabetic Medicine 1998; 15: 539-53.
21. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Trea-cher DF, Turner RC. Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-9.
22. Lobstein T, Baur L, Uauy R. Obesity in children and young people: a crisis in public health. Obesity Reviews 2004; 5: 74-85.
23. Reilly JJ, Methven E, McDowell ZC, et al. Health consequences of obesity. Arch Dis Child 2003; 88: 748-52.
24. Aggoun Y. Obesity, Metabolic Syndrome, and Cardiovascular Disease. Pediatric Research 2007; 61: 653-9.
25. Berenson GS, Srinivasan SR, Bao W, Newman WP, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. New Engl J Med 1998; 338: 1650-6.
26. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24: 683-9.
27. Saland JM. Update on the metabolic syndrome in children. Curr Opin Ped 2007; 19: 183-91.
28. Kelishadi R. Childhood overweight, obesity, and the metabolic syndrome in developing countries. Epidemiologic Reviews 2007; 3: 1-15.
29. Matsuzawa Y, Funahashi T, Nakamura T. Molecular mechanism of vascular disease in metabolic syndrome X. J Diabetes Complications 2002; 16: 17-8.
30. Funahashi T, Nakamura T, Shimomura I, et al. Role of adipocytokines on the pathogenesis of atherosclerosis in visceral obesity. Intern Med 1999; 38: 202-6.
31. Ouchi N, Kihara S, Arita Y, et al. Novel modulator for en-dothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 1999; 100: 2473-6.
32. Ouchi N, Ohishi M, Kihara S, et al. Association of hypoa-diponectinemia with impaired vasoreactivity. Hypertension 2003; 42: 231-4.
33. Ryo M, Nakamura T, Kihara S, et al. Adiponectin as a bio-marker of the metabolic syndrome. Circ J 2004; 68: 975-81.
34. Tedgui A, Mallat Z. Anti-inflammatory mechanisms in the vascular wall. Circ Res 2001; 88: 877-87.
35. Esposito K, Pontillo A, Giugliano F, et al. Association of low interleukin-10 levels with the metabolic syndrome in obese women. J Clin Endocrinol Metab 2003; 88: 1055-8.
36. Wetsendorp RG, Langermans JA, Huizinga TW, et al. Genetic influence on cytokine production and fatal meningo-coccal disease. Lancet 1997; 349: 170-3.
37. Smith DA, Irving SD, Sheldon J, Cole D, Kaski JC. Serum levels of the antiinflammatory cytokine interleukin-10 are decreased in patients with unstable angina. Circulation 2001; 104: 746-9.
38. van Exel E, Gussekloo J, de Craen AJM, Bootsmavan der Wiel A, Frölich M, Westendorp RGJ. Inflammation and stroke: the Leiden 85-Plus Study. Stroke 2002; 33: 1135-8.
39. van Exel E, Gussekloo J, de Craen AJM, Frölich M, Bootsmavan der Wiel A, Westendorp RG. Low production capacity of interleukin-10 associates with the metabolic syndrome and type2 diabetes. The Leiden 85-Plus Study. Diabetes 2002; 51: 1088-92.
40. Manigrasso MR, Ferroni P, Santilli F, et al. Association between circulating adiponectin and interleukin-10 levels in android obesity: effects of weight loss. J Clin Endocrinol Metab 2005; 90: 5876-8.
41. Bottner A, Kratzch J, Muller G, et al. Gender differences of adiponectin levels develop during the progression of puberty. J Clin Endocrinol Metab 2004; 89: 4053-61.
42. Martos-Moreno G, Barrios V, Argente J. Normative data for adiponectin, resistin, interleukin 6, and leptin/receptor ratio in a healthy Spanish pediatric population: relationship with sex steroids. Eur J Endocrinol 2006; 155: 429-34.